Experience in neuromuscular diseases in children and adolescents and their comorbidities in a tertiary hospital

Table 2 Respiratory treatment and rehabilitation

	Group I. (n = 16)	Group II. (n = 41)	Group III (n = 42)	P
Musculoskeletal Physiotherapy	13 (86.7%)	30 (75%)	25 (61%)	0.117
Respiratory physiotherapy	11 (73.3)^a,b	9 (22.5%)	13 (31.7%)	0.002
NIV	7 (46.7%) ^a,b	3 (7.5%)	2 (4.9%)	< 0.001
Tracheotomy	1 (6.7%)	1 (2.5%)	1 (2.4%)	0.742
IMV	1 (6.7%)	1 (2.5%)	1 (2.4%)	0.759

Group I Involvement of the motor neuron; Group II: Peripheral neuropathies; Group III: Myopathies
NIV Non-invasive ventilation. IMV Invasive mechanical ventilation. ^a: p < 0.05 between group I and group II; ^b: p < 0.05 between group I and group III

ISSN: 1824-7288